Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
作者信息
Tuttle R Michael, Haugen Bryan, Perrier Nancy D
机构信息
1 Memorial Sloan Kettering Cancer Center , New York, New York.
2 University of Colorado School of Medicine , Aurora, Colorado.
出版信息
Thyroid. 2017 Jun;27(6):751-756. doi: 10.1089/thy.2017.0102. Epub 2017 May 19.
Abstract
摘要
相似文献
1
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
Thyroid. 2017 Jun;27(6):751-756. doi: 10.1089/thy.2017.0102. Epub 2017 May 19.
2
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin. 2018 Jan;68(1):55-63. doi: 10.3322/caac.21439. Epub 2017 Nov 1.
3
Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
Histol Histopathol. 2021 Mar;36(3):239-248. doi: 10.14670/HH-18-277. Epub 2020 Nov 10.
4
Anaplastic thyroid carcinoma.
Semin Diagn Pathol. 2020 Sep;37(5):248-256. doi: 10.1053/j.semdp.2020.06.005. Epub 2020 Jun 24.
5
Commentary on the study of Walczyk et al. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
Clin Endocrinol (Oxf). 2019 Aug;91(2):245-246. doi: 10.1111/cen.14010. Epub 2019 May 24.
6
Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging.
Thyroid. 2019 May;29(5):619-624. doi: 10.1089/thy.2018.0286. Epub 2019 Apr 27.
7
Fatal outcome of an anaplastic thyroid tumour.
BMJ Case Rep. 2017 Oct 25;2017:bcr-2017-221672. doi: 10.1136/bcr-2017-221672.
8
Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
Oral Oncol. 2017 Aug;71:81-86. doi: 10.1016/j.oraloncology.2017.06.004. Epub 2017 Jun 10.
9
Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients.
Front Endocrinol (Lausanne). 2021 Jul 27;12:704596. doi: 10.3389/fendo.2021.704596. eCollection 2021.
10
[A case of anaplastic transformation of thyroid carcinoma in the cervical lymph node metastasis].
Gan No Rinsho. 1985 Mar;31(3):318-22.
引用本文的文献
1
Development of a new TNM staging system for poorly differentiated thyroid carcinoma: a multicenter cohort study.
Front Endocrinol (Lausanne). 2025 Aug 19;16:1586542. doi: 10.3389/fendo.2025.1586542. eCollection 2025.
2
Ultrasound features and thyroid function of patients with papillary thyroid carcinoma for predicting metastatic cervical lymph nodes with atypical ultrasound features.
Front Oncol. 2025 Aug 8;15:1628205. doi: 10.3389/fonc.2025.1628205. eCollection 2025.
3
Differentiating oncocytic carcinoma from oncocytic adenoma: a comprehensive evaluation of preoperative characteristics and diagnostic approaches in a retrospective cohort study.
Ann Surg Treat Res. 2025 Aug;109(2):105-112. doi: 10.4174/astr.2025.109.2.105. Epub 2025 Jul 30.
4
Predictive factors for failure in patients with N1b papillary thyroid carcinoma.
World J Surg Oncol. 2025 Jul 31;23(1):307. doi: 10.1186/s12957-025-03694-5.
5
Structure-based molecular screening and dynamic simulation of phytocompounds targeting VEGFR-2: a novel therapeutic approach for papillary thyroid carcinoma.
Front Pharmacol. 2025 Jun 9;16:1583329. doi: 10.3389/fphar.2025.1583329. eCollection 2025.
6
Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre.
Front Endocrinol (Lausanne). 2025 May 27;16:1513893. doi: 10.3389/fendo.2025.1513893. eCollection 2025.
7
Associations between pathological features and radioactive iodine-refractory recurrent papillary thyroid carcinoma: with mutation analysis using recurrent samples.
BMC Endocr Disord. 2025 May 20;25(1):134. doi: 10.1186/s12902-025-01954-9.
8
Prognostic factors for progression free survival in patients with medullary thyroid cancer: a multicenter cohort study.
Updates Surg. 2025 May 20. doi: 10.1007/s13304-025-02193-2.
9
A Challenging Diagnosis of Papillary Thyroid Carcinoma Arising From Malignant Struma Ovarii.
Cureus. 2025 Apr 17;17(4):e82465. doi: 10.7759/cureus.82465. eCollection 2025 Apr.
10
Positive preoperative circulating tumor cells level associated with lymph node metastasis in papillary thyroid carcinoma patients with capsular invasion.
World J Surg Oncol. 2025 May 14;23(1):190. doi: 10.1186/s12957-025-03842-x.
本文引用的文献
1
Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
J Clin Oncol. 2016 Dec 20;34(36):4415-4420. doi: 10.1200/JCO.2016.68.9372. Epub 2016 Oct 28.
2
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
Thyroid. 2016 Mar;26(3):373-80. doi: 10.1089/thy.2015.0315. Epub 2016 Feb 25.
3
4
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?
Thyroid. 2015 Oct;25(10):1106-14. doi: 10.1089/thy.2015.0104. Epub 2015 Aug 12.
5
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
6
Update on differentiated thyroid cancer staging.
Endocrinol Metab Clin North Am. 2014 Jun;43(2):401-21. doi: 10.1016/j.ecl.2014.02.010.
7
Prognostic nomograms to predict oncological outcome of thyroid cancers.
J Clin Endocrinol Metab. 2013 Dec;98(12):4768-75. doi: 10.1210/jc.2013-2318. Epub 2013 Oct 23.
8
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
J Clin Endocrinol Metab. 2013 Jan;98(1):172-80. doi: 10.1210/jc.2012-2458. Epub 2012 Nov 12.
9
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8.
Zotero 插件